Earns Placement on Global List for Fifth Consecutive Year
CAMBRIDGE, Mass., Oct. 12 /PRNewswire-FirstCall/ -- Genzyme Corporation
(Nasdaq: GENZ) announced today that scientists have again named the company
a top employer in a survey ranking the reputations of biotechnology and
pharmaceutical companies. Genzyme was ranked fifth out of nearly 500
companies. Over the past five years Genzyme has consistently placed among
the top 10 of all biotechnology and pharmaceutical companies. Genzyme was
the highest ranked company headquartered in New England.
The survey, which was commissioned by Science magazine and the American
Association for the Advancement of Science (AAAS), identifies the top 20
companies with the best reputations as employers. More than 3,000 Science
readers and other industry representatives participated in the survey.
Genzyme received its highest ranking in the category of doing important,
quality research, followed by being judged an innovative leader in the
industry and a socially responsible company.
"To be recognized as a top life sciences employer for five consecutive
years is a consistent reflection on our scientists and the innovative work
that they do in the laboratories every day," said Richard Gregory, senior
vice president and head of research at Genzyme. "Genzyme's recognition for
doing important quality research underscores our commitment to making a
major positive impact on the lives of people with serious diseases."
About the Survey
Science and AAAS commissioned a web-based survey to determine the
Biotechnology and Pharmaceutical companies with the best reputations as
employers. This web-based study was administered from May 2 to June 6,
2007. For this year's survey, a mixed methodology was used. The first part
of this methodology included e-mailed invitations to AAAS members,
ScienceCareers.org registrants, and Science website visitors registered
with AAAS. The second part of the methodology included an e-mail blast to
more than 950 human resource contacts from the ScienceCareers.org database.
Survey respondents were asked to write in the names of companies they
considered best, average and worst employers. They then rated these
companies on 23 different attributes. Attribute categories included
Corporate Image, Leadership and Direction, Financial Prowess, Work
Culture/Environment, Work/Life Balance, Academics and Collegial Exchange,
and Compensation and Benefits. Nearly one-third (29%) of participants came
from outside the United States - primarily Western Europe.
"We are honored to be ranked as one of the top five companies in the
world for scientists," said Zoltan Csimma, Genzyme's chief human resources
officer. "Genzyme values its scientists for their contributions to finding
innovative solutions for today's toughest medical challenges. We are
committed to attracting and retaining talented people in all areas of the
company."
Scientists working at Genzyme are developing new and next-generation
therapies in several areas of medicine using a wide range of technologies.
The company is bringing new treatments to patients with genetic diseases,
kidney disease, cancer, osteoarthritis, and transplant and immune diseases.
The company is also a leader in the development of diagnostic and genetic
tests.
The survey results will appear in a special business supplement of the
12 October 2007 issue of Science. To read the full survey, please visit:
http://sciencecareers.sciencemag.org/career_development/previous_issues/art
icl es/2007_10_12/science_opms_r0700045 (Due to length of URL, please copy
and paste into your browser).
For information about other recognition Genzyme has received, please
visit: http://www.genzyme.com/corp/structure/awards_genz.asp
For information about careers at Genzyme, please visit:
http://www.genzyme.com/careers
About Genzyme
One of the world's leading biotechnology companies, Genzyme is
dedicated to making a major positive impact on the lives of people with
serious diseases. Since 1981, the company has grown from a small start-up
to a diversified enterprise with more than 9,500 employees in locations
spanning the globe and 2006 revenues of $3.2 billion. In 2007, Genzyme was
chosen to receive the National Medal of Technology, the highest honor
awarded by the President of the United States for technological innovation.
In 2006 and 2007, Genzyme was selected by FORTUNE as one of the "100 Best
Companies to Work for" in the United States.
With many established products and services helping patients in nearly
90 countries, Genzyme is a leader in the effort to develop and apply the
most advanced technologies in the life sciences. The company's products and
services are focused on rare inherited disorders, kidney disease,
orthopaedics, cancer, transplant, and diagnostic testing. Genzyme's
commitment to innovation continues today with a substantial development
program focused on these fields, as well as immune disease, infectious
disease, and other areas of unmet medical need.
Genzyme(R) is a registered trademark of Genzyme Corporation. All rights
reserved.
Genzyme's press releases and other company information are available at
http://www.genzyme.com and by calling Genzyme's investor information line
at 1-800-905-4369 within the United States, or 1-678-999-4572 outside the
United States.
CONTACT: Investors Media
Catherine Forte Sarah Millerick
(617) 768-6881 (617) 768-6438
SOURCE Genzyme Corporation
 back to top
Related links:
http://www.genzyme.com
http://www.prnewswire.com/comp/104284.html/
CONTACT:
Investors, Catherine Forte, +1-617-768-6881,
or Media, Sarah Millerick, +1-617-768-6438, both of Genzyme
Corporation
|
